Balkrishna N. Jahagirdar
Expertise in
34
conditions

Dr. Balkrishna N. Jahagirdar

Oncology | Hematology
Lakeview Breast Health Center
927 Churchill St W, 
Stillwater, MN 
Accepting New Patients
Offers Telehealth
Expertise in
34
conditions
Lakeview Breast Health Center
927 Churchill St W, 
Stillwater, MN 

Overview

Medicine is my passion, my calling and the love of my life (as much as my wife, two sons, parents and siblings). I consider myself fortunate to be able to make it my profession. My goal is to deliver state-of-the-art medical care to the community in a compassionate manner. I look at the patient as a whole – not just the cancer. I understand the hardship that caregivers face and do my best to provide all the knowledge and support they need. My patients and their caregivers are my heroes for the courage and bravery they show in facing illness.

Dr. Jahagirdar is highly rated in 34 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Familial Colorectal Cancer, Non-Hodgkin Lymphoma, and Colorectal Cancer.

Dr. Jahagirdar is board certified in American Board Of Internal Medicine-Medical Oncology and American Board Of Internal Medicine-Hematology. He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 4 clinical trials. Dr. Jahagirdar is currently accepting new patients.

Specialties

Oncology
Hematology

Licenses

Internal Medicine in MN

Board Certifications

American Board Of Internal Medicine-Medical Oncology
American Board Of Internal Medicine-Hematology

Fellowships

University of Minnesota - 2002

Hospital Affiliations

Regions Hospital
Park Nicollet Methodist Hospital
M Health Fairview University Of Mn Medical Center
Hudson Hospital
Lakeview Memorial Hospital

Languages Spoken

English
Hindi
Marathi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Lakeview Breast Health Center
927 Churchill St W, Stillwater, MN 55082

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1 Study of rSIFN-co for Subjects With Advanced Solid Tumors Where Interferons Are Known to Have Demonstrated Antitumor Activity
A Phase 1 Study of rSIFN-co for Subjects With Advanced Solid Tumors Where Interferons Are Known to Have Demonstrated Antitumor Activity
Enrollment Status: Terminated
Publish Date: February 25, 2025
Intervention Type: Biological
Study Phase: Phase 1
Pilot Study of IGF-Methotrexate Conjugate in the Treatment of Myelodysplastic Syndrome, CMML and Oligoblastic AML
Pilot Study of IGF-Methotrexate Conjugate in the Treatment of Myelodysplastic Syndrome, CMML and Oligoblastic AML
Enrollment Status: Terminated
Publish Date: May 21, 2024
Intervention Type: Drug
Study Drugs: Insulin-Like Growth Factor, Methotrexate
Study Phase: Phase 1/Phase 2
(STM-03) Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
(STM-03) Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
Enrollment Status: Terminated
Publish Date: May 24, 2023
Intervention Type: Drug
Study Phase: Phase 1
(STM-03) Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
(STM-03) Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
Enrollment Status: Completed
Publish Date: September 24, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

11 Total Publications

Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.
Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.
Journal: Blood advances
Published: May 18, 2026
Similar Doctors
Expertise in
9
conditions
Dr. Mukta Arora
Hematology | Oncology
Expertise in
9
conditions
Dr. Mukta Arora
Hematology | Oncology
Referral may be required

Fairview Pharmacy Services LLC

516 Delaware St SE, 
Minneapolis, MN 
 (20.8 miles away)
612-273-2800
Languages Spoken:
English
See accepted insurances

Mukta Arora is a Hematologist and an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Arora is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
13
conditions
Dr. Yoav H. Messinger
Hematology | Oncology
Expertise in
13
conditions
Dr. Yoav H. Messinger
Hematology | Oncology
Referral may be required

Childrens Home Care Pharmacy

2530 Chicago Ave, 
Minneapolis, MN 
 (22.6 miles away)
612-813-5940
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients

Yoav Messinger is a Hematologist and an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Messinger is highly rated in 13 conditions, according to our data. His clinical expertise encompasses DICER1 Syndrome, Sertoli-Leydig Cell Tumor, Pleuropulmonary Blastoma, Leydig Cell Testicular Tumor, and Bone Marrow Transplant. Dr. Messinger is currently accepting new patients.

Expertise in
10
conditions
Dr. Christopher L. Moertel
Hematology | Oncology
Expertise in
10
conditions
Dr. Christopher L. Moertel
Hematology | Oncology
Referral may be required

University Of Minnesota Medical Center Fairview Riverside

2450 Riverside Ave, 
Minneapolis, MN 
 (21.2 miles away)
612-365-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Christopher Moertel is a Hematologist and an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Moertel is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, and RASopathies. Dr. Moertel is currently accepting new patients.

Frequently Asked Questions about Dr. Balkrishna N. Jahagirdar

How do I make an appointment with Dr. Balkrishna N. Jahagirdar?

You can book an appointment with Dr. Balkrishna N. Jahagirdar by calling their office at 651-430-4612. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Balkrishna N. Jahagirdar a top-rated expert for B-Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Balkrishna N. Jahagirdar is classified as an Distinguished expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Balkrishna N. Jahagirdar specialize in?

While Dr. Balkrishna N. Jahagirdar is a Oncology, they have specific expertise in B-Cell Lymphoma, Familial Colorectal Cancer, and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Balkrishna N. Jahagirdar participate in research or clinical trials?

Yes. Dr. Balkrishna N. Jahagirdar has published 11 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Dr. Balkrishna N. Jahagirdar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Balkrishna N. Jahagirdar accept my insurance?

Dr. Balkrishna N. Jahagirdar accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 651-430-4612 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jahagirdar's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 24 Advanced Conditions
    View All 132 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile